Comming Soon ...
Internal and External/peer group Quality Control Program
Improve your trueness
Make decision according to sigma
Multiple analytes on one instrument
Multiple sample types
All-in-one test cartridge
Automatic self-check system
No additional calibration necessary
Throughput: 480 tests/hour 580 tests/hour with ISE
Test items on board: 36 items + ISE 3 items
Reaction volume: 120– 300 micro-liter
Patient samples on board: 72 patient samples, 30 STAT samples
Reaction volume: 140– 300 micro-liter
Test items on board: 24 items + ISE 3 items / 36 items + ISE 3 items
Patient samples on board: 30 patient samples
Throughput: 270 tests/hour 450 tests/hour with ISE
R1: 140 ～ 300μl (1μl step）
R2: 20 ～ 260μl (1μl step）
News and Announcements
Lead researcher Dr. Heidi May, a cardiovascular epidemiologist at the Institute, and colleagues found that individuals with low levels of both total vitamin D and bioavailable vitamin D were more likely to experience poor cardiovascular outcomes. Bioavailable vitamin D is vitamin D that has been absorbed into the bloodstream but has not attached to surrounding proteins. The researchers recently presented their findings at the American College of Cardiology Scientific Sessions in Chicago, IL. To reach their results, Dr. May and colleagues analyzed the vitamin D levels of 4,200 individuals aged 52-76. Of these, around a quarter had diabetes and around 70% had coronary artery disease. The team focused on measuring the participants levels of various vitamin D metabolites - elements of the vitamin that are produced during metabolism - and assessed whether they were associated with future cardiac events. Reference: http://www.medicalnewstoday.com/
Author: Patricia Slev, PhD, DABCC // Date: MAR.1.2016 // Source: Clinical Laboratory News Topics: Infectious Diseases, Immunology, Multiplex Lab Test After two decades without much change in HIV laboratory testing, suddenly there are many testing options and more than a few questions from laboratorians and physicians alike. The new testing strategy capitalizes on recent advances in technology and new Food and Drug Administration (FDA)-approved assays in the U.S. The Centers for Disease Control and Prevention (CDC) published the most recent recommendations for HIV laboratory testing, including a new algorithm, in 2014. This algorithm calls for screening ...
NPT is proud to present new products from top well-known brands. NPT is now working with Ortho Diagnostics. For more information please click here.
Check out our availability of kits, instruments here
Subscribe to our newsletter to receive news, updates, and another stuff by email.